clinical trial · NCT06427395
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Primary Biliary CholangitisSaroglitazar Magnesium 1 mg
brief summary
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
started
Jul 16, 2024
primary completion
Apr 18, 2027
completion
Jul 18, 2027
last updated
Feb 9, 2026
detailed description
A Multicenter, Open-Label, Extension Clinical trial to evaluate Safety and Efficacy of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis (PBC)
official title
A Multicenter, Open-Label, Extension Clinical Trial to Evaluate Safety and Efficacy of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis (PBC)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol